Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.
about
De novo autoimmune hepatitis in liver transplant: State-of-the-art reviewAutoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future ResearchThe immunoreactive patient: Rejection and autoimmune diseaseAutoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.Liver transplantation and autoimmune hepatitis.Clinical relevance of autoantibodies after pediatric liver transplantation.Histopathology of de novo autoimmune hepatitis.Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.Post-transplant liver biopsy and the immune response: lessons for the clinician.Acute and acute severe (fulminant) autoimmune hepatitis.Liver transplantation and autoimmune liver diseases.Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S-transferase theta 1.Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.Autoimmune Hepatitis in the Liver Transplant Graft.Plasma cell hepatitis induced by the termination of antiviral therapy for recurrent hepatitis C after living donor liver transplantation.Long-term outcomes of de novo autoimmune hepatitis in pediatric liver transplant recipients.Rethinking immune hepatitis, an old concept for liver allograft rejection: Relevance of glutathione S-transferase T1 mismatch
P2860
Q26766082-956874D2-AEDB-4978-A60D-09FF559D6B9EQ26786188-B57F9FAD-B234-4F63-9E35-949F2E7E5537Q26860876-5C62B445-91FE-44A6-B182-81B03534734BQ33977201-2A49A0C4-F052-489E-952B-4B27B24F8AEEQ35066577-B4C8F871-4297-4617-B441-A81A22F1C475Q36815305-C9642B02-D79A-48FA-B140-90D01AB8F87AQ37989409-BDB9B4EC-5138-4534-B1FA-6AB1B920E3CBQ38007886-78860F50-7A8E-4400-9C13-8E55506231BDQ38053173-99A54720-66B2-4C61-B104-D1B9522ACE4CQ38054513-03FE8D11-5AD2-40D7-B5D4-8C232911AFEBQ38123133-783C4D4C-A2D6-49AC-9A14-1D0A34616417Q38852645-1D5B2179-6775-40A5-A3C9-7B0E9378B4B7Q38973707-1FF037B6-3930-43F7-93D3-1A78F24D3D3FQ39001834-4BA5C111-C978-4B65-8385-FA81C1EF05E9Q39212663-16AB90FD-5D69-4D1A-969E-88B582666EB1Q50547085-ADF2486D-C063-418F-B4E9-24DB44E1FA4CQ53259695-B6311230-FEC5-43F0-BAB4-074D0A555AC2Q58798093-3A5C1D97-51FD-433A-B615-59890B307BB5
P2860
Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Outcome and risk factors of de ...... g-donor liver transplantation.
@ast
Outcome and risk factors of de ...... g-donor liver transplantation.
@en
type
label
Outcome and risk factors of de ...... g-donor liver transplantation.
@ast
Outcome and risk factors of de ...... g-donor liver transplantation.
@en
prefLabel
Outcome and risk factors of de ...... g-donor liver transplantation.
@ast
Outcome and risk factors of de ...... g-donor liver transplantation.
@en
P2093
P1433
P1476
Outcome and risk factors of de ...... ng-donor liver transplantation
@en
P2093
Aya Miyagawa-Hayashino
Hironori Haga
Hiroto Egawa
Koichi Tanaka
Sachiko Minamiguchi
Takaki Sakurai
Toshiaki Manabe
P304
P356
10.1097/01.TP.0000132328.33460.43
P577
2004-07-01T00:00:00Z